Youngevity Announces Successful Completion of Pilot Study
"The Youngevity research protocols are comprehensive and rigorous. We are very pleased that the initial pilot program was a success and brings us confidence that the larger scale study should run smoothly and provide promising results." The RCFFN is one of the most advanced bioprocessing and product development facilities in Canada and around the world. The RCFFN has focused on value-added foods, food bioactives, and nutraceuticals that offer health promotion, performance enhancement, and disease prevention and management since 2006.
The pilot study was performed as the initial phase to the comprehensive and detailed study the RCFFN is conducting on the signature "90 For Life" Youngevity product set and their effects on various health biomarkers, which include those for weight management, inflammation, and blood sugar issues. The Ethics Committee at the University of Manitoba reviewed and approved the Youngevity products and their dosage levels in the rigorous protocols that will be used for the study. It was deemed that the Youngevity products chosen were highly tolerable and well within the range of the confidence levels to initiate the comprehensive study.
Dr. Ramprasath Vanu Ramkumar, Adjunct Professor and Research Associate for the Department of Human Nutritional Sciences at RCFFN, said, "The Youngevity research protocols are comprehensive and rigorous. We are very pleased that the initial pilot program was a success and brings us confidence that the larger scale study should run smoothly and provide promising results."
"The successful completion of the pilot study is another milestone for Youngevity, and we expect the research will be completed by the first quarter of 2014 and will be reported within the same time frame," said Steve Wallach, Youngevity's Chief Executive Officer. "This is Youngevity's second large scale research study performed by a recognized academic research institution to provide the best analysis of these signature Youngevity products. In the past year, the Nutraceutical Research Institute at Clemson University directed a research study demonstrating the safety, inflammatory benefits, and effect on various human cancer cells lines of the Youngevity products, Beyond Tangy Tangerine® and Ultimate Classic Plant Derived Minerals."
Related News
-
Youngevity Opens Operations in Columbia
SAN DIEGO, CA, Jan. 11, 2018: Youngevity International, Inc. today announced the opening of its operations in Colombia. Youngevity has identified Colombia as one of the primary direct selling markets in Latin America. Youngevity announced that this expansion effort will be spearheaded by Country M... Read More...Youngevity To Ring Nasdaq Opening Bell on January 3, 2018
Youngevity selected by Nasdaq as a Fit Week CompanySAN DIEGO, CA and New York, NY, Dec. 19, 2017 -- Youngevity International, Inc., a leading omni-direct lifestyle company, today announced it will ring in the new year on January 3, 2018 at The Nasdaq Stock Market Opening Bell ceremony at the... Read More...
Youngevity Completes Acquisition of Future Global Vision
SAN DIEGO, CA -- Nov 20, 2017-- Youngevity International, Inc., a leading omni-direct lifestyle company, today announced it has closed the acquisition of the assets of Future Global Vision.Future Global Vision was formed in March 2013 by Raul Serrano and his team to help people achieve healt... Read More...
Youngevity Expands Into Small Business Lending and Merchant Services
David Rutz Appointed Vice President of Global ServicesSAN DIEGO, CA--(Mar 15, 2016) - Youngevity International, Inc., a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channe... Read More...
